Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.
Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, Hong K, Mestas J, Zisman D, Ardehali A, Saggar R, Lynch JP 3rd, Ross DJ, Strieter RM. Belperio JA, et al. Among authors: Mestas J. J Immunol. 2005 Nov 15;175(10):6931-9. doi: 10.4049/jimmunol.175.10.6931. J Immunol. 2005. PMID: 16272353
Cancer CXC chemokine networks and tumour angiogenesis.
Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Strieter RM, et al. Among authors: Mestas J. Eur J Cancer. 2006 Apr;42(6):768-78. doi: 10.1016/j.ejca.2006.01.006. Epub 2006 Feb 28. Eur J Cancer. 2006. PMID: 16510280 Review.
Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.
Phillips RJ, Mestas J, Gharaee-Kermani M, Burdick MD, Sica A, Belperio JA, Keane MP, Strieter RM. Phillips RJ, et al. Among authors: Mestas J. J Biol Chem. 2005 Jun 10;280(23):22473-81. doi: 10.1074/jbc.M500963200. Epub 2005 Mar 31. J Biol Chem. 2005. PMID: 15802268
72 results
Jump to page
Feedback